-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Lantern Pharma Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q3 2024.
- Lantern Pharma Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.42 USD/shares, a 44.8% decline year-over-year.
- Lantern Pharma Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.77 USD/shares, a 26.4% decline year-over-year.
- Lantern Pharma Inc. annual Earnings Per Share, Basic for 2023 was -1.47 USD/shares, a 12.2% decline from 2022.
- Lantern Pharma Inc. annual Earnings Per Share, Basic for 2022 was -1.31 USD/shares, a 15.9% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)